JP2006526393A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006526393A5 JP2006526393A5 JP2006508083A JP2006508083A JP2006526393A5 JP 2006526393 A5 JP2006526393 A5 JP 2006526393A5 JP 2006508083 A JP2006508083 A JP 2006508083A JP 2006508083 A JP2006508083 A JP 2006508083A JP 2006526393 A5 JP2006526393 A5 JP 2006526393A5
- Authority
- JP
- Japan
- Prior art keywords
- flavivirus
- packaging
- protein
- construct
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000710831 Flavivirus Species 0.000 claims description 27
- 101710172711 Structural protein Proteins 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 230000014509 gene expression Effects 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 229960005486 vaccine Drugs 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims 31
- 210000004027 cell Anatomy 0.000 claims 15
- 239000004098 Tetracycline Substances 0.000 claims 6
- 229960002180 tetracycline Drugs 0.000 claims 6
- 229930101283 tetracycline Natural products 0.000 claims 6
- 235000019364 tetracycline Nutrition 0.000 claims 6
- 150000003522 tetracyclines Chemical class 0.000 claims 6
- 241001465754 Metazoa Species 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 101710117545 C protein Proteins 0.000 claims 3
- 101710204837 Envelope small membrane protein Proteins 0.000 claims 3
- 101710145006 Lysis protein Proteins 0.000 claims 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 3
- 235000018102 proteins Nutrition 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 241000710912 Kunjin virus Species 0.000 claims 2
- 101710189818 Non-structural protein 2a Proteins 0.000 claims 2
- 210000004102 animal cell Anatomy 0.000 claims 2
- 230000001024 immunotherapeutic effect Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 1
- 241000725619 Dengue virus Species 0.000 claims 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 101800000512 Non-structural protein 1 Proteins 0.000 claims 1
- 101800000508 Non-structural protein 5 Proteins 0.000 claims 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 108010087302 Viral Structural Proteins Proteins 0.000 claims 1
- 241000710886 West Nile virus Species 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
- 229960001230 asparagine Drugs 0.000 claims 1
- 235000009582 asparagine Nutrition 0.000 claims 1
- 229940009098 aspartate Drugs 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical group N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 238000009169 immunotherapy Methods 0.000 claims 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 1
- 238000013518 transcription Methods 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
- 108091006106 transcriptional activators Proteins 0.000 claims 1
- 230000014616 translation Effects 0.000 claims 1
- 241000700605 Viruses Species 0.000 description 3
- 239000002245 particle Substances 0.000 description 2
- 102000004961 Furin Human genes 0.000 description 1
- 108090001126 Furin Proteins 0.000 description 1
- 230000002424 anti-apoptotic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 108700041737 bcl-2 Genes Proteins 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000034217 membrane fusion Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003902842A AU2003902842A0 (en) | 2003-06-06 | 2003-06-06 | Flavivirus replicon packaging system |
| PCT/AU2004/000752 WO2004108936A1 (en) | 2003-06-06 | 2004-06-07 | Flavivirus replicon packaging system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006526393A JP2006526393A (ja) | 2006-11-24 |
| JP2006526393A5 true JP2006526393A5 (enExample) | 2007-06-28 |
Family
ID=31953883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006508083A Pending JP2006526393A (ja) | 2003-06-06 | 2004-06-07 | フラビウイルスレプリコンパッケージング系 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060280757A1 (enExample) |
| EP (1) | EP1633877A4 (enExample) |
| JP (1) | JP2006526393A (enExample) |
| CN (1) | CN1798845A (enExample) |
| AU (1) | AU2003902842A0 (enExample) |
| CA (1) | CA2528046A1 (enExample) |
| NZ (1) | NZ543419A (enExample) |
| WO (1) | WO2004108936A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008051266A2 (en) * | 2006-02-13 | 2008-05-02 | Integral Molecular, Inc. | A dengue reporter virus and methods of making and using the same |
| EP1991709B1 (en) | 2006-02-27 | 2017-01-25 | The Board of Regents of The University of Texas System | Pseudoinfectious flavivirus and uses thereof |
| UA103316C2 (uk) | 2008-03-14 | 2013-10-10 | Санофі Пастер Біолоджікс Ко. | Вакцини на базі флавівірусів з дефектною реплікацією і вектори для одержання вакцин |
| EP2310510B1 (en) * | 2008-07-17 | 2015-05-06 | Medigen, Inc. | Idna vaccines and methods for using the same |
| CN102363751A (zh) * | 2011-03-24 | 2012-02-29 | 中山大学 | 登革病毒样颗粒及其制备方法与应用 |
| BE1023557B1 (fr) | 2014-02-10 | 2017-05-03 | Univercells Sa | Systeme, appareil et procede pour la production de biomolecules |
| JP6975643B2 (ja) * | 2015-05-13 | 2021-12-01 | シーエスエル ベーリング ジーン セラピー インコーポレイテッド | レンチウイルスベクターのバイオ生産法 |
| US10799575B2 (en) | 2015-06-25 | 2020-10-13 | Technovax, Inc. | Flavivirus and alphavirus virus-like particles (VLPS) |
| CU20200018A7 (es) * | 2017-09-11 | 2020-11-30 | Tengen Biomedical Company | Arbovirus de crecimiento defectuoso específico de un mamífero |
| CN113637697B (zh) * | 2021-07-13 | 2024-06-14 | 中山大学 | 一种denv-4全长感染性克隆及其构建方法 |
| CN114317563B (zh) * | 2021-12-17 | 2023-09-05 | 华南理工大学 | 提高基因表达的rna复制子及其应用 |
| CN119899808A (zh) * | 2024-12-05 | 2025-04-29 | 深圳湾实验室 | 登革减毒株及其应用 |
| CN120818539B (zh) * | 2025-09-16 | 2025-12-09 | 成都锦城学院 | 黄病毒的复制依赖的rna重组实验系统的建立和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6893866B1 (en) * | 1997-11-28 | 2005-05-17 | The Crown In The Right Of The Queensland Department Of Health | Flavivirus expression and delivery system |
| US20060204523A1 (en) * | 2001-11-26 | 2006-09-14 | Khromykh Alexander A | Flavivirus vaccine delivery system |
| AU2003267943C1 (en) * | 2002-02-26 | 2009-05-21 | Altravax, Inc. | Novel flavivirus antigens |
-
2003
- 2003-06-06 AU AU2003902842A patent/AU2003902842A0/en not_active Abandoned
-
2004
- 2004-06-07 JP JP2006508083A patent/JP2006526393A/ja active Pending
- 2004-06-07 NZ NZ543419A patent/NZ543419A/en unknown
- 2004-06-07 WO PCT/AU2004/000752 patent/WO2004108936A1/en not_active Ceased
- 2004-06-07 CN CNA200480015488XA patent/CN1798845A/zh active Pending
- 2004-06-07 EP EP04736184A patent/EP1633877A4/en not_active Withdrawn
- 2004-06-07 CA CA002528046A patent/CA2528046A1/en not_active Abandoned
- 2004-06-07 US US10/559,146 patent/US20060280757A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8252574B2 (en) | Pseudoinfectious flavivirus and uses thereof | |
| JP3681369B2 (ja) | キメラおよび／または増殖制限されたフラビウイルス | |
| Gehrke et al. | Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line | |
| Pang et al. | Development of Dengue virus type 2 replicons capable of prolonged expression in host cells | |
| Harvey et al. | Tetracycline-inducible packaging cell line for production of flavivirus replicon particles | |
| JP2006526393A5 (enExample) | ||
| US8394620B2 (en) | Two-component genome flavivirus and uses thereof | |
| WO2010085358A2 (en) | Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof | |
| JP2005510244A5 (enExample) | ||
| ES2376354T3 (es) | Nueva part�?cula recombinante similar al virus de la hepatitis c humano y procedimiento para producir la misma. | |
| CA2528046A1 (en) | Flavivirus replicon packaging system | |
| Hong et al. | Advances and challenges of reverse genetics in mosquito-borne flaviviruses: focus on Japanese encephalitis virus | |
| Du et al. | An in vitro recombination-based reverse genetic system for rapid mutagenesis of structural genes of the Japanese encephalitis virus | |
| Roby et al. | Nucleic acid-based infectious and pseudo-infectious flavivirus vaccines | |
| Khromykh et al. | Tetracycline-Inducible Packaging Cell Line | |
| JPWO2023164441A5 (enExample) | ||
| Suzuki et al. | REVISION OF JVI00662-08 |